Modulight Biotherapeutics
United States
- Boston, Massachusetts
- 13/11/2025
- Seed
- $12,000,000
Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
- Industry Biotechnology Research
- Website https://www.modulight.bio/
- LinkedIn https://www.linkedin.com/company/modulight-bio/
Related People
Yotam EldarFounder
United States -
Boston, Massachusetts
Experienced leader of operational and technology teams, with a passion for solving complex multidisciplinary problems in a data-driven and results-oriented manner, to achieve a solid and positive impact in the world.
Long track record of excellence across several fields and industries - from leading complex special operations and projects, through medical practice, to biotech innovation.
Currently Yotam is focused on building a transformative solution for intractable neurological conditions, utilizing his deep technical understanding, creativity, leadership and networking skills to create a truly meaningful, positive change for patients.
Golden Analytics | $7,000,000 | (Apr 9, 2026)
HexemBio | $10,400,000 | (Apr 9, 2026)
E2 - Endovascular Engineering | $80,000,000 | (Apr 9, 2026)
True Footage | $40,000,000 | (Apr 9, 2026)
Petwealth | $1,700,000 | (Apr 9, 2026)
Pomo | $4,500,000 | (Apr 9, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
Trent AI | $13,000,000 | (Apr 9, 2026)
GoSats - The simplest onramp to Digital Assets in India | $5,000,000 | (Apr 9, 2026)
Life Biosciences | $80,000,000 | (Apr 9, 2026)
Noon | $44,000,000 | (Apr 7, 2026)
Miravoice | $6,300,000 | (Apr 7, 2026)